Current Headlines

  1. Catalent To Acquire Cook Pharmica For $950M

    Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, recently announced it has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services.

  2. Integrated Project Services, LLC (IPS) And G-CON Manufacturing Introduce iCON, A Turnkey Modular Facility Platform Solution For BioManufacturing

    IPS-Integrated Project Services, LLC (IPS), a leading global provider of engineering, architecture, project controls, construction management, commissioning and qualification services, and G-CON Manufacturing, Inc. the leading provider of prefabricated cleanrooms, recently announced the unveiling of the iCON™ brand which represents the collective facility design and build capabilities of the two companies.

  3. Brammer Bio Completes Expansion Of Cell And Gene Therapy Clinical Manufacturing Facilities

    Brammer Bio ("Brammer"), a cell and gene therapy contract development and manufacturing organization (CDMO), today announced completion of its clinical capacity expansion in Alachua, Florida.

  4. MilliporeSigma Expands Celonic’s Upstream Capabilities With Mobius Single-Use Bioreactors

    MilliporeSigma recently announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of MilliporeSigma’s Mobius® single-use bioreactors.

  5. Kaneka Eurogentec Announces The Construction Of A New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility

    Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced recently that its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter.

  6. Bio-Rad Launches RT-PCR Assay Kit For Simultaneous Detection Of Zika, Dengue, And Chikungunya Viruses

    Bio-Rad Laboratories, Inc. recently announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4), and chikungunya (CHIKV) arbovirus RNAs. The assay comes with all the controls researchers need to internally validate the results. The RT-PCR kit was introduced earlier this year in markets outside the U.S.

  7. Pfizer Presents Positive Pivotal Data for PF-05280014, an Investigational Biosimilar to Herceptin (trastuzumab), at the European Society for Medical Oncology (ESMO) 2017 Congress

    Pfizer Inc. (NYSE:PFE) today announced positive findings from REFLECTIONS B327-02 (n=707), a pivotal Phase 3 randomized, double-blind comparative safety and efficacy study of the company’s investigational trastuzumab biosimilar (PF-05280014) versus Herceptin 1(trastuzumab), at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid. Positive data from a supplemental study, REFLECTIONS B327-04 (n=226), were also presented at the meeting. PF-05280014 is being developed by Pfizer as a potential biosimilar to Herceptin.

  8. CRB Provides Modern Facility Design For Bayer North America Crop Science Headquarters

    Bayer’s North American Crop Science Division Headquarters required a modernization to be reflective of a modern brand, accommodate increased staff levels and attract professionals to Bayer. CRB provided mechanical, electrical and plumbing services to help create an efficient, modern facility within the existing building envelope on Bayer’s growing campus.

  9. Outsourced Pharma San Francisco 2017 Agenda Update

    Outsourced Pharma San Francisco will feature Achaogen as its Spotlight Leadership Company at its conference for professionals of biotech, pharma, and contract development and manufacturing organizations (October 17 - 18 at the Hyatt Regency San Francisco Airport). The session is titled: Spotlight Leadership Company: Achaogen.

  10. BPOG, NIIMBL To Collaborate On U.S.-Specific Roadmap For Biopharmaceutical Manufacturing Industry

    BioPhorum Operations Group (BPOG) and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) are pleased to announce they have entered into a collaboration agreement to develop a US-specific roadmap for the biopharmaceutical manufacturing industry to complement the existing BPOG global roadmap.